NeurAxis, a medical technology company specializing in neuromodulation therapies, will release its first quarter 2026 financial results on May 12, before the market opens. The company will also host a conference call at 9:00 am ET that day to discuss the results and provide a business update. NeurAxis focuses on its IB-Stim technology, FDA-cleared for treating functional abdominal pain related to IBS and other conditions, with ongoing clinical trials for additional uses. This update is important for investors tracking the company's progress and adoption of its therapies.
Serko Limited conducted a shareholder meeting on August 23, 2026, chaired by Claudia Batten with CFO Shane Sampson present to assist. Shareholders were invited to vote and ask questions via an online portal, with support from external auditors Deloit...
A Federal Reserve Bank of Cleveland study found that showing people Bitcoin's past 12-month gain of 14.3% increased their desired crypto holdings by about 2 percentage points and actual purchases by 2.5 points. Crypto owners expected much higher retu...
Ethereum (ETH) price broke above $2,500, reaching its highest level since January, driven by $697 million inflows into US spot Ethereum ETFs and a $1.69 billion short squeeze over three days. Institutional interest is strong, with staking participati...
A study by Vietnamese researchers shows that higher carbon prices in the EU are causing Bitcoin mining to shift to Russia, where there is no carbon tax, making mining cheaper. Companies operating in both regions switch off European machines and activ...
Ledger quietly patched a serious security flaw in its Ethereum hardware wallet app on August 12, 2026, which allowed malicious apps to replace legitimate transactions during signing. The vulnerability was found internally by Ledger's Donjon security ...
